Search results for "marker"

showing 10 items of 3799 documents

Colonoscopy and reduction of colorectal cancer risk by molecular tumor subtypes: a population-based case-control study

2020

AbstractObjectiveIn previous studies, the protective effect of colonoscopy was generally stronger for distal than for proximal colorectal cancer (CRC). This study aimed to investigate whether the association of colonoscopy and CRC risk varies according to major molecular pathological features and pathways of CRC.DesignPopulation-based case-control study from Germany, including 2132 patients with a first diagnosis of CRC and information on major molecular tumor markers, and 2486 control participants without CRC. Detailed participant characteristics were collected by standardized questionnaires and information on previous colonoscopy was derived from medical records. Polytomous logistic regre…

AdenomaMaleProto-Oncogene Proteins B-rafOncologymedicine.medical_specialtyColorectal cancerPopulationRectumColonoscopymedicine.disease_cause03 medical and health sciences0302 clinical medicineGermanyInternal medicineBiomarkers TumormedicineHumanseducationneoplasmsAgedAged 80 and overeducation.field_of_studyHepatologyCpG Island Methylator Phenotypemedicine.diagnostic_testbusiness.industryGastroenterologyCase-control studyCancerColonoscopyOdds ratioDNA MethylationMiddle Agedmedicine.diseaseConfidence intervaldigestive system diseasesmedicine.anatomical_structureCase-Control Studies030220 oncology & carcinogenesisMutationCpG IslandsFemaleMicrosatellite Instability030211 gastroenterology & hepatologyObservational studyKRASColorectal Neoplasmsbusiness
researchProduct

Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins

1995

Applying immunohistochemical procedures for the detection of eight different cytokeratin (CK) polypeptides and other differentiation markers, we compared the staining patterns of normal cutaneous structures with those of benign adnexal tumors (n = 65). Syringomas exhibited a marker pattern highly reminiscent of that seen in normal dermal eccrine ducts (EMA in peripheral cells, CK 10 in intermediate cells, and CK 6, CK 19, and CEA in luminal cells). Nodular hidradenomas exhibited complex patterns suggesting relationship between tumor cells, including clear cells, and normal secretory coil cells (CK 7, CK 8, CK 19, and EMA); however, dermal-duct and epidermoid differentiation were also detect…

AdenomaPathologymedicine.medical_specialtySkin NeoplasmsHistologyHidradenomaCellular differentiationDermatologyBiologyBinding CompetitiveInner root sheathPathology and Forensic MedicineCytokeratinReference ValuesBiomarkers TumormedicineCarcinomaHumansNeoplasms Basal CellAdenoma Sweat GlandSyringomaMyoepithelial cellAntibodies MonoclonalCell Differentiationmedicine.diseaseCarcinoma Adenoid CysticImmunohistochemistrySweat GlandsStainingEpidermal CellsKeratinsImmunohistochemistryEpidermisJournal of Cutaneous Pathology
researchProduct

Follicular adenomas exhibit a unique metabolic profile. ¹H NMR studies of thyroid lesions.

2013

Thyroid cancer is the most common endocrine malignancy. However, more than 90% of thyroid nodules are benign. It remains unclear whether thyroid carcinoma arises from preexisting benign nodules. Metabolomics can provide valuable and comprehensive information about low molecular weight compounds present in living systems and further our understanding of the biology regulating pathological processes. Herein, we applied ¹H NMR-based metabolic profiling to identify the metabolites present in aqueous tissue extracts of healthy thyroid tissue (H), non-neoplastic nodules (NN), follicular adenomas (FA) and malignant thyroid cancer (TC) as an alternative way of investigating cancer lesions. Multivar…

Adenomaendocrine systemMagnetic Resonance Spectroscopyendocrine system diseaseslcsh:Rlcsh:MedicineMultivariate AnalysisBiomarkers TumorHumansMetabolomicslcsh:QThyroid Neoplasmslcsh:ScienceResearch ArticlePloS one
researchProduct

Histomorphological evaluation, cell proliferation and endothelial immunostaining in oral and maxillofacial myofibroblastic lesions.

2022

Myofibroblasts (MF) are mesenchymal cells with features of both fibroblasts and smooth muscle cells. Although these are usually reactive cells, they can lead to myofibroblastic tumors that may share clinical and histomorphological characteristics but with different prognosis. The aim of this study is to perform a histomorphological evaluation as well as to compare and evaluate two different cell proliferation immunomarkers and two endothelial markers in a group of oral and maxillofacial myofibroblastic lesions (MFL). Cross-sectional and retrospective study. Demographic, clinical, histomorphological and immunohistochemical characteristics of 39 cases of MFL were analyzed. Immunohistochemical…

Adolescentorthognathic surgeryImmunohistochemistryGranuloma Plasma CellCross-Sectional StudiesOtorhinolaryngologysystematic reviewBiomarkers TumorHumansSurgeryvirtual planningFemaleMyofibroblastsGeneral DentistryUNESCO:CIENCIAS MÉDICASBiomarkersRetrospective StudiesCell ProliferationMedicina oral, patologia oral y cirugia bucal
researchProduct

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer

2019

There is no sufficient evidence to establish a standard of care for patients with brain metastases (BM) from HER2Data of 154 patients were retrospectively collected at 14 Italian institutions through a specifically designed database.Median overall survival (OS) was 24.5 months. Patients receiving surgery/stereotactic radiosurgery experienced longer OS compared to those receiving whole-brain radiotherapy or no treatment (33.5 vs. 11.4 months; hazard ratio = 0.34; 95% confidence interval, 0.22-0.52; P .001). Interestingly, whole-brain radiotherapy did not improve OS compared to no treatment (11.4 vs. 9.8 months; hazard ratio = 0.99; 95% confidence interval, 0.62-1.62; P = .99). HER2-targeted …

Adult0301 basic medicineCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSocio-culturaleBreast NeoplasmsLapatinibTreatment experiencedRadiosurgerySRS03 medical and health sciences0302 clinical medicineBreast cancerTrastuzumabInternal medicineHER2 Positive Breast CancerBiomarkers TumormedicineHumansAgedRetrospective Studiesbusiness.industryLapatinibTrastuzumabMiddle AgedWBRTPrognosismedicine.diseaseCombined Modality TherapyConfidence intervalSurvival RateRadiation therapyLapatinib SRS Surgery Trastuzumab WBRT030104 developmental biologyReceptors EstrogenOncology030220 oncology & carcinogenesisLapatinib; SRS; Surgery; Trastuzumab; WBRTSurgeryFemaleNeoplasm Recurrence LocalbusinessFollow-Up Studiesmedicine.drugClinical Breast Cancer
researchProduct

Relationship between apoptosis and survival molecules in human cumulus cells as markers of oocyte competence

2017

SummaryTo select from a single patient the best oocytes able to reach the blastocyst stage, we searched for valuable markers for oocytes competence. We evaluated the DNA fragmentation index (DFI) and the level of some survival molecules, such as AKT, pAKT and pERK1/2, in individual cumulus cell–oocyte complexes (COC). The study included normo-responder women. The average age of the patients was 34.3. DFI in cumulus cells was evaluated using the terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labelling (TUNEL) assayin situ. AKT, pAKT and pERK1/2 were measured by immunological assay and densitometric analysis of fluorescent signals using NIS-Elements BR 3.10 image software. Statisti…

Adult0301 basic medicineCell SurvivalApoptosisDNA FragmentationBiologyMolecular markerAndrology03 medical and health sciences0302 clinical medicineOocyte competencemedicineHumansProspective StudiesBlastocystPhosphorylationSettore BIO/06 - Anatomia Comparata E CitologiaExtracellular Signal-Regulated MAP KinasesCells CulturedCumulus Cells030219 obstetrics & reproductive medicineTUNEL assayApoptosiEmbryoCell BiologyOocyteIn vitroCell biology030104 developmental biologymedicine.anatomical_structureHuman cumulus cellTerminal deoxynucleotidyl transferaseApoptosisSurvival moleculeOocytesDNA fragmentationFemaleProto-Oncogene Proteins c-aktBiomarkersDevelopmental Biology
researchProduct

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

2018

Purpose This multicenter phase II trial evaluated lurbinectedin (PM01183), a selective inhibitor of active transcription of protein-coding genes, in patients with metastatic breast cancer. A unicenter translational substudy assessed potential mechanisms of lurbinectedin resistance. Patients and Methods Two arms were evaluated according to germline BRCA1/2 status: BRCA1/2 mutated (arm A; n = 54) and unselected ( BRCA1/2 wild-type or unknown status; arm B; n = 35). Lurbinectedin starting dose was a 7-mg flat dose and later, 3.5 mg/m2 in arm A. The primary end point was objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST). The translational substudy of resist…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyGenes BRCA2Genes BRCA1Phases of clinical researchAntineoplastic AgentsBreast NeoplasmsHeterocyclic Compounds 4 or More RingsMice03 medical and health sciences0302 clinical medicineGermline mutationInternal medicineBiomarkers TumorClinical endpointAnimalsHumansMedicineProgression-free survivalGerm-Line MutationAgedDose-Response Relationship DrugErratabusiness.industryMiddle Agedmedicine.diseaseXenograft Model Antitumor AssaysMetastatic breast cancerProgression-Free SurvivalClinical trial030104 developmental biologyOncologyResponse Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesisBiomarker (medicine)FemalebusinessCarbolinesJournal of Clinical Oncology
researchProduct

Congenital undifferentiated sarcoma associated to BCOR-CCNB3 gene fusion

2017

Small round cell sarcomas are aggressive bone and soft tissue tumors that predominantly affect children and young adults. A new group of sarcomas with a recurrent BCOR-CCNB3 gene fusion has been recently identified in previously unclassifiable small round cell sarcomas. BCOR-CCNB3 sarcomas share clinical and pathologic similarities with Ewing sarcoma, but show a stronger male predilection and less aggressiveness, as well as distinct gene expression profiling and pangenomic SNP array analyses. We report the unusual case of a congenital BCOR-CCNB3 retroperitoneal sarcoma in a female born at 34th gestational week, which was diagnosed in necropsy after 21hours of life. Immunohistochemical analy…

Adult0301 basic medicinePathologymedicine.medical_specialtyOncogene Proteins FusionTumor suppressor geneCD99Soft Tissue NeoplasmsCyclin BBiologyPathology and Forensic MedicineDiagnosis DifferentialFusion gene03 medical and health sciences0302 clinical medicineProto-Oncogene ProteinsBiomarkers TumormedicineHumansSMARCB1SarcomaCell Biologymedicine.diseaseRepressor ProteinsGene expression profiling030104 developmental biology030220 oncology & carcinogenesisCancer researchImmunohistochemistryFemaleSarcomaGene FusionSNP arrayPathology - Research and Practice
researchProduct

Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis

2015

AbstractRheumatoid arthritis is a chronic autoimmune-based inflammatory disease that leads to progressive joint degeneration, disability, and an increased risk of cardiovascular complications, which is the main cause of mortality in this population of patients. Although several biomarkers are routinely used in the management of rheumatoid arthritis, there is a high demand for novel biomarkers to further improve the early diagnosis of rheumatoid arthritis, stratification of patients, and the prediction of a better response to a specific therapy.In this study, the metabolomics approach was used to provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and mon…

Adult0301 basic medicinerheumatoid arthritismedicine.medical_specialtyMagnetic Resonance SpectroscopyClinical BiochemistryPopulationPharmaceutical ScienceDiseaseCreatineGastroenterologyAnalytical ChemistryArthritis Rheumatoid03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMetabolomicsValineInternal medicineDrug DiscoverymedicineHumanseducation1H NMR spectroscopySpectroscopyAged030203 arthritis & rheumatologyeducation.field_of_studyCreatinineMiddle Agedmedicine.diseasemetabolomics030104 developmental biologychemistryRheumatoid arthritisDisease ProgressionFemaleProtonsLeucineBiomarkersJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Type of culture media does not affect embryo kinetics: a time-lapse analysis of sibling oocytes

2013

Are the morphokinetics of growing embryos affected by the type of culture media utilized?Morphokinetic parameters used for embryo selection are not affected between the two different concept culture media analyzed.Studies on the effect of culture media on human embryos have focused on evaluating different in-house and commercially available media as well as comparing outcomes among different commercial media. Nonetheless, the evaluation of embryo development in these studies was based on static observations and very little is known from a dynamic point of view.Prospective cohort study, October 2010 and April 2011.University-affiliated infertility center. Patients undergoing egg donation (n …

AdultAdolescentPregnancy RateBiologyTime-Lapse ImagingCohort StudiesAndrologyYoung AdultPregnancymedicineHumansEmbryo ImplantationProspective StudiesSiblingPregnancyOocyte DonationFifth thoracic vertebraRehabilitationObstetrics and GynecologyEmbryoAnatomymedicine.diseaseCulture MediaKineticsPregnancy rateBlastocystReproductive MedicineSpainOocyte donationOocytesPregnancy TwinEctogenesisFemaleBiomarkersHuman Reproduction
researchProduct